CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that it has out-licensed its ...
Repare Therapeutics Inc. (NASDAQ:RPTX) is one of the best Canadian stocks with huge upside potential. As May began, Repare Therapeutics announced an out-licensing agreement with the Canadian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback